Information about confirmatory studies required for new drugs conditionally approved by health canada: a cross-sectional study

HIGHLIGHTS

• who: Joel Lexchin from the School of Health Policy and Management, York University, Toronto, Ontario, Canada, Department of have published the paper: Information about confirmatory studies required for new drugs conditionally approved by Health Canada: A cross-sectional study, in the Journal: PLOS ONE of October/11,/2022
• what: This study examines the depth of information about methodology and patient demographics in the confirmatory studies. Once the studies are completed, they are evaluated by Health Canada similar to studies submitted in the premarket period and if they are acceptable to Health Canada , the conditions are . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.